USFDA Seeking Approval of DCVax

Early detection of breast cancer has helped prevent many fatalities, but what if we had a vaccination for all types of cancer? There is great hope for a cancer vaccination in the works as we speak. The PEI (Paul-Ehrlich-Institut,) which is the FDA of Germany, has found a way to get an accelerated approval to get a cancer vaccine called DCVax possibly approved by the USFDA (United States Food and Drug Administration). Over the past two and half years, a company by the name of Northwest Biotherapeutics has made major progress in finding a vaccination for all types of cancer through recent clinical trials. The trials have shown tremendous results with increased life expectancy and substantial results in the shrinkage of tumors.

Cancer has been around for over a 100 years and we still have yet to find a cure, or some sort of vaccination. Cancer is best described as an uncontrolled growth of malignant (cancer) cells attack the lymph nodes and your body’s immune system. Some types of cancer may cause alterations that affect regular cell growth and division. When these alterations, or mutations occur, they develop a mass of tissue called a tumor (Breast Cancer Treatment). With this vaccine, DCVax, participants that were included in these clinical trials have shown amazing results in overall survival time and shrinkage of tumors.

The desire of finding a vaccination for cancer is remarkably high in today’s society. For some reason, FDA is hesitant about authorizing the DCVax. A corporation by the name of Dendreon discovered the first ever FDA approved vaccine called Provenge. It was given to individuals for the treatment of particular forms of prostate cancer. The patients that receive this vaccine has decreased the chance of death by 22...

... middle of paper ...

...29 Apr. 2014. .

“NW Bio Announces Two German Approvals: “Hospital Exemption” for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement.” Northwest Biotherapeutics The future of cancer medicine now. Northwest Biotherapeutics, 10 Mar. 2014. Web. 29 Apr. 2014. .

‘PROVENGE® (sipuleucel-T) Is FDA Approved.” Dendreon.com. Dendreon-Targeting Cancer, Transforming Lives, 2013. Web. 30 Apr. 2014. .

“FDA Approves Cyramza for Stomach Cancer.” U.S. Food and Drug Administration. 21 Mar. 2014. Web. 29 Apr. 2014. .